TAT-Gap19(I130A)
Tocris Bioscience | Catalog # 7402
Product Description
TAT-Gap19(I130A) is a control peptide for TAT-Gap19 (Cat. No. 6227), a Cx43 hemichannel blocker. TAT-Gap19(I130A) consists of TAT-GAP19 with a I130A amino acid residue change at a key residue for GAP19 activity. In C6 glioma cells expression Cx43, TAT-GAP19(1130A) does not inhibit [Ca2+]i-triggered ATP release at 200 μM. TAT-Gap19(I130A) is cell permeable.
Product Specifications for TAT-Gap19(I130A)
Molecular Weight
Formula
Storage
Purity
InChI Key
SMILES
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solubility | Soluble to 2mg/ml in water |
Calculators
Background References
References are publications that support the biological activity of the product.
- Walrave Inhibition of connexin43 hemichannels impairs spatial short-term memory without affecting spatial working memory. Front.Cell Neurosci. 2016 PMID: 28066184
- Wang Selective inhibition of Cx43 hemichannels by Gap19 and its impact on myocardial ischemia/reperfusion injury. Basic Res.Cardiol. 2013 PMID: 23184389
Product Documents for TAT-Gap19(I130A)
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Product Specific Notices for TAT-Gap19(I130A)
For research use only
Related Research Areas
Customer Reviews for TAT-Gap19(I130A)
There are currently no reviews for this product. Be the first to review TAT-Gap19(I130A) and earn rewards!
Have you used TAT-Gap19(I130A)?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review